17.58

1.91% +0.33

Indivior Plc (INDV)

Overview News Price History Discussions Forecast

Indivior Plc stock is currently priced at $17.58, with a 24-hour trading volume of 180.38K. It has seen a +1.91% increased in the last 24 hours and a -14.54% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $17.44 pivot point. If it approaches the $17.75 resistance level, significant changes may occur.

Previous Close:

$17.25

Open:

$17.28

24h Volume:

180.38K

Market Cap:

$2.38B

Revenue:

$1.12B

Net Income/Loss:

$5.00M

P/E Ratio:

EPS:

Net Cash Flow:

$-383.00M

1W Performance:

-5.08%

1M Performance:

-14.54%

6M Performance:

-11.21%

1Y Performance:

+0.00%

1D Range:

$17.23

$17.79

52W Range:

$14.38

$23.22

Indivior Plc Stock (INDV) Company Profile

Name

Indivior Plc

Sector

Healthcare (1191)

Industry

Drug Manufacturers - Specialty & Generic (4)

Phone

Address

Employee

1,000

Twitter

Next Earnings Date

Latest SEC Filings

INDV's Discussions on Twitter

Indivior Plc Stock (INDV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-13-23	Initiated	Northland Capital	Outperform

Indivior Plc Stock (INDV) Latest News

Indivior PLC (INDV) Q1 Earnings and Revenues Lag Estimates

Zacks Investment Research

Indivior (INDV) Surges 5.6%: Is This an Indication of Further Gains?

Zacks Investment Research

Indivior PLC (INDV) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Zacks Investment Research

Indivior Plc Stock (INDV) Financials Data

Indivior Plc (INDV) Revenue 2024

INDV reported a revenue (TTM) of $1.12 billion for the quarter ending March 31, 2024, a +18.57% rise year-over-year.

Indivior Plc (INDV) Net Income 2024

INDV net income (TTM) was $5.00 million for the quarter ending March 31, 2024, a +110.00% increase year-over-year.

Indivior Plc (INDV) Cash Flow 2024

INDV recorded a free cash flow (TTM) of -$383.00 million for the quarter ending March 31, 2024, a -1,765% decrease year-over-year.

Indivior Plc (INDV) Earnings per Share 2024

INDV earnings per share (TTM) was $0.01 for the quarter ending March 31, 2024, a +102.38% growth year-over-year.

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.